Surgical Quality Improvement

Orthopaedic Surgery Outcomes

January 1, 2019 – December 31, 2019

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall orthopaedic surgery ACS NSQIP performance benchmarked against 610 participating sites.

Orthopaedic Surgery (610 Sites)NObservedExpected
30 Day Mortality5620.18%0.28%
30 Day Morbidity5622.14%3.81%
Cardiac5620.00%0.38%
Pneumonia5620.18%0.43%
Unplanned Intubation5620.18%0.22%
Ventilator > 48 Hours5610.00%0.08%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus?5621.25%0.89%
Urinary Tract Infection (UTI)5620.71%0.63%
Surgical Site Infection (SSI)5620.89%1.67%
Sepsis5620.36%0.40%
Return to Operating Room (ROR)5621.25%2.23%
Readmission5624.09%4.84%

American College of Surgeons National Surgical Quality Improvement Program, 2020.
ACS NSQIP® Semiannual Report July 23, 2020, Chicago: American College of Surgeons.

In addition to overall orthopaedic surgery ACS NSQIP® outcomes data, data specific to total knee arthroplasty (TKA) and total hip arthroplasty (THA) are provided. TKA performance is benchmarked against 487 participating sites; THA performance is benchmarked against 502 sites.